Elke Kunisch1, Raimund W Kinne1, Rayya J Alsalameh2, Saifeddin Alsalameh3. 1. Experimental Rheumatology Unit, Department of Orthopedics, Jena University Hospital, Jena, Germany. 2. Arthritis Research Unit, Department of Molecular & Experimental Medicine, The Scripps Research Institute (TSRI), La Jolla, California, USA. 3. Department of Medicine 3, University Hospital Erlangen, University of Erlangen-Nürnberg, Erlangen, Germany.
Abstract
AIM: In osteoarthritis chondrocytes, matrix metalloproteases (MMPs) and their inhibitors are induced by interleukin (IL)-1beta or tumor necrosis factor (TNF)-alpha and balanced by inhibitors, but their messenger RNA (mRNA) expression has not been studied in individual cells. METHODS: Normal articular chondrocytes (10 donors; age 50 ± 6 years, mean ± SEM) were stimulated in a monolayer for 24 h with IL-1beta, TNF-alpha, or transforming growth factor (TGF)-beta1 (10 ng/mL each), alone or in combination. mRNA expression for MMP-1, MMP-3 and tissue inhibitor of metalloproteinase (TIMP)-1 was studied by in situ hybridization ((35) S-cRNA) and quantitative reverse transcription polymerase chain reaction (RT-PCR) (n ≥ 3 each). RESULTS: Whereas < 5% chondrocytes constitutively expressed MMP-1, a higher percentage expressed MMP-3 and TIMP-1 (31.1 ± 1.8%; 36.7 ± 2.8%, respectively). Upon stimulation with IL-1beta, TNF-alpha or IL-1beta/TNF-alpha, the percentage of cells positive for MMP-1, MMP-3 and TIMP-1 rose significantly (IL-1beta: 31.5%, 54.5% and 60.2%, respectively; TNF-alpha: 35.4%, 56.6%, 50.9%; IL-1beta/TNF-alpha: 38.8%, 45.2%, 52.1%). In bulk population (RT-PCR), mRNA for MMP-1 and MMP-3 was also induced by IL-1beta (11.9-fold, 1.2-fold, respectively), TNF-alpha (4.8-fold, 1.0-fold) or IL-1beta/TNF-alpha (14.7-fold, 1.4-fold), an effect attenuated by TGF-beta1. TIMP-1 mRNA, in contrast, was down-regulated by IL-1beta, TNF-alpha or IL-1beta/TNF-alpha, an effect again partially reverted by TGF-beta1. Finally, collagen type II mRNA was down-regulated by IL-1beta, TNF-alpha or IL-1beta/TNF-alpha (by 90%, 50% and 98%, respectively) and that of collagen type I was up-regulated (5.7-fold, 3.0-fold, 3.7-fold). CONCLUSIONS: Up-regulation of MMP-1/MMP-3 by IL-1beta and/or TNF-alpha in a fraction of chondrocytes in vitro suggests that a subpopulation of catabolic cells may also exist in osteoarthritis. These cells may undergo considerable dedifferentiation, as indicated by a decreased collagen-II/collagen-I ratio.
AIM: In osteoarthritis chondrocytes, matrix metalloproteases (MMPs) and their inhibitors are induced by interleukin (IL)-1beta or tumor necrosis factor (TNF)-alpha and balanced by inhibitors, but their messenger RNA (mRNA) expression has not been studied in individual cells. METHODS: Normal articular chondrocytes (10 donors; age 50 ± 6 years, mean ± SEM) were stimulated in a monolayer for 24 h with IL-1beta, TNF-alpha, or transforming growth factor (TGF)-beta1 (10 ng/mL each), alone or in combination. mRNA expression for MMP-1, MMP-3 and tissue inhibitor of metalloproteinase (TIMP)-1 was studied by in situ hybridization ((35) S-cRNA) and quantitative reverse transcription polymerase chain reaction (RT-PCR) (n ≥ 3 each). RESULTS: Whereas < 5% chondrocytes constitutively expressed MMP-1, a higher percentage expressed MMP-3 and TIMP-1 (31.1 ± 1.8%; 36.7 ± 2.8%, respectively). Upon stimulation with IL-1beta, TNF-alpha or IL-1beta/TNF-alpha, the percentage of cells positive for MMP-1, MMP-3 and TIMP-1 rose significantly (IL-1beta: 31.5%, 54.5% and 60.2%, respectively; TNF-alpha: 35.4%, 56.6%, 50.9%; IL-1beta/TNF-alpha: 38.8%, 45.2%, 52.1%). In bulk population (RT-PCR), mRNA for MMP-1 and MMP-3 was also induced by IL-1beta (11.9-fold, 1.2-fold, respectively), TNF-alpha (4.8-fold, 1.0-fold) or IL-1beta/TNF-alpha (14.7-fold, 1.4-fold), an effect attenuated by TGF-beta1. TIMP-1 mRNA, in contrast, was down-regulated by IL-1beta, TNF-alpha or IL-1beta/TNF-alpha, an effect again partially reverted by TGF-beta1. Finally, collagen type II mRNA was down-regulated by IL-1beta, TNF-alpha or IL-1beta/TNF-alpha (by 90%, 50% and 98%, respectively) and that of collagen type I was up-regulated (5.7-fold, 3.0-fold, 3.7-fold). CONCLUSIONS: Up-regulation of MMP-1/MMP-3 by IL-1beta and/or TNF-alpha in a fraction of chondrocytes in vitro suggests that a subpopulation of catabolic cells may also exist in osteoarthritis. These cells may undergo considerable dedifferentiation, as indicated by a decreased collagen-II/collagen-I ratio.
Authors: Matlock A Jeffries; Madison Donica; Lyle W Baker; Michael E Stevenson; Anand C Annan; Mary Beth Humphrey; Judith A James; Amr H Sawalha Journal: Arthritis Rheumatol Date: 2016-06 Impact factor: 10.995